Fmoc-Ala-Ala-Asn-PAB-PNP - CAS 1834516-06-1

Fmoc-Ala-Ala-Asn-PAB-PNP - CAS 1834516-06-1 Catalog number: BADC-00493

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Fmoc-Ala-Ala-Asn-PAB-PNP is an excellent and highly discriminating inhibitor widely used in biomedicine for multiple purposes. It is widely used in the field of drug development, especially in the targeted detection and attenuation of malignancies and cancers.

Category
ADCs Linker
Product Name
Fmoc-Ala-Ala-Asn-PAB-PNP
CAS
1834516-06-1
Catalog Number
BADC-00493
Molecular Formula
C39H38N6O11
Molecular Weight
766.75
Fmoc-Ala-Ala-Asn-PAB-PNP

Ordering Information

Catalog Number Size Price Quantity
BADC-00493 -- $--
Inquiry
Description
Fmoc-Ala-Ala-Asn-PAB-PNP is an excellent and highly discriminating inhibitor widely used in biomedicine for multiple purposes. It is widely used in the field of drug development, especially in the targeted detection and attenuation of malignancies and cancers.
Synonyms
Fmoc-Ala-Ala-Asn-PABC-PNP; (9H-fluoren-9-yl)methyl ((S)-1-(((S)-1-(((S)-4-amino-1-((4-((((4-nitrophenoxy)carbonyl)oxy)methyl)phenyl)amino)-1,4-dioxobutan-2-yl)amino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)carbamate
IUPAC Name
[4-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]phenyl]methyl (4-nitrophenyl) carbonate
Canonical SMILES
CC(C(=O)NC(CC(=O)N)C(=O)NC1=CC=C(C=C1)COC(=O)OC2=CC=C(C=C2)[N+](=O)[O-])NC(=O)C(C)NC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35
InChI
InChI=1S/C39H38N6O11/c1-22(41-35(47)23(2)42-38(50)54-21-32-30-9-5-3-7-28(30)29-8-4-6-10-31(29)32)36(48)44-33(19-34(40)46)37(49)43-25-13-11-24(12-14-25)20-55-39(51)56-27-17-15-26(16-18-27)45(52)53/h3-18,22-23,32-33H,19-21H2,1-2H3,(H2,40,46)(H,41,47)(H,42,50)(H,43,49)(H,44,48)/t22-,23-,33-/m0/s1
InChIKey
KVDVZTLIGXDKKC-BHWLZUDQSA-N
Density
1.382±0.06 g/cm3
Solubility
Soluble in DMSO
Appearance
Solid
Purity
≥95%
Shipping
Room temperature, or blue ice upon request.
Storage
Store at -20 °C, keep in dry and avoid sunlight
Boiling Point
1117.7±65.0 °C at 760 mmHg

Fmoc-Ala-Ala-Asn-PAB-PNP, a synthetic compound, plays a pivotal role in modern biomedical research and drug development due to its highly discriminating inhibitory properties. This molecular entity is engineered to interact specifically with target proteins, thereby modulating their function in pathways relevant to disease processes. Particularly in the realm of oncology, Fmoc-Ala-Ala-Asn-PAB-PNP has gained attention for its ability to selectively inhibit enzymes and pathways that are dysregulated in cancer. Its specific activity profile provides an advantage in minimizing off-target effects, thereby enhancing the therapeutic window. The compound’s stability and the efficiency with which it can be incorporated into larger molecular frameworks make it an ideal candidate for developing targeted therapies aimed at malignant tissues.

In drug discovery, the strategic incorporation of Fmoc (Fluorenylmethyloxycarbonyl) group enhances the compound’s stability, allowing it to withstand complex biological environments without premature degradation. This stability is critical in maintaining the integrity of the drug as it navigates through the biological pathways to reach its target location. Additionally, the Ala-Ala-Asn peptide sequence enhances the molecule’s ability to penetrate cells, ensuring that the inhibitory action of Fmoc-Ala-Ala-Asn-PAB-PNP is effectively delivered where it’s most needed. In cancer research, this precision is crucial, as it can lead to significant improvements in targeting tumor cells while sparing normal, healthy cells from unnecessary chemical exposure.

Furthermore, the PAB (p-Aminobenzyl) spacer in the molecule is instrumental in facilitating controlled drug release. In the context of cancer therapeutics, this characteristic is particularly beneficial as it allows the active drug to be released at specific sites within the body, directly into tumor cells or the surrounding microenvironment. This targeted release mechanism not only improves the efficacy of the drug but also reduces collateral damage to non-cancerous cells, thereby diminishing the side effects commonly associated with conventional chemotherapy. Incorporating such a feature demonstrates the advancement in design strategies employed in current drug discovery programs, emphasizing precision medicine.

The potential of Fmoc-Ala-Ala-Asn-PAB-PNP extends beyond oncology. Its structural components allow it to be adapted for use against a variety of pathogenic targets, opening avenues in infectious diseases and autoimmune disorders. By altering the peptide framework, various derivatives can be synthesized to interact with different proteins, offering a versatile platform for the development of novel therapeutics. This adaptability is crucial in drug discovery, where the ability to modulate chemical structures to target new and emerging threats rapidly is paramount. In essence, Fmoc-Ala-Ala-Asn-PAB-PNP serves as a scaffolding molecule that can be customized to meet the demands of numerous therapeutic areas.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Historical Records: Fmoc-Ala-Ala-Asn-PAB-PNP
Why Choose BOC Sciences?

Customer Support

Providing excellent 24/7 customer service and support

Project Management

Offering 100% high-quality services at all stages

Quality Assurance

Ensuring the quality and reliability of products or services

Global Delivery

Ensuring timely delivery of products worldwide

Questions & Comments
Verification code
Send Inquiry
Verification code
Inquiry Basket